Alimera announces first patient randomized in radiation retinopathy trial being conducted by the drcr retina network

Protocol al is studying iluvien or faricimab (6.0 mg) injections versus observation for the prevention of visual acuity loss due to radiation retinopathy protocol al is studying iluvien or faricimab (6.0 mg) injections versus observation for the prevention of visual acuity loss due to radiation retinopathy
ALIM Ratings Summary
ALIM Quant Ranking